Julien Gander
General Counsel bei IDORSIA LTD
Aktive Positionen von Julien Gander
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IDORSIA LTD | General Counsel | - | - |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Julien Gander
Ehemalige bekannte Positionen von Julien Gander
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOLECULAR PARTNERS AG | General Counsel | 01.07.2016 | 01.11.2022 |
Lonza, Inc.
 Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | General Counsel | - | - |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | General Counsel | - | - |
Ausbildung von Julien Gander
| University of Cambridge | Graduate Degree |
Statistik
International
| Schweiz | 5 |
| Vereinigtes Königreich | 2 |
| Vereinigte Staaten | 2 |
Operativ
| General Counsel | 4 |
| Graduate Degree | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| IDORSIA LTD | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Lonza AG
Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Health Technology |
Lonza, Inc.
Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Process Industries |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Health Technology |
- Börse
- Insiders
- Julien Gander
- Erfahrung
